FDA: No Such Thing as No Drug Risk

September 12th, 2006 |
Image for FaceBook

Share this post:
Facebook | Twitter | Google+ | LinkedIn | Pinterest | Reddit | Email
This post can be linked to directly with the following short URL:

The audio player code can be copied in different sizes:
144p, 240p, 360p, 480p, 540p, Other

The audio player code can be used without the image as follows:

This audio file can be linked to by copying the following URL:

Right/Ctrl-click to download the audio file.
Connected Social Media - iTunes | Spotify | Google | Stitcher | TuneIn | Twitter | RSS Feed | Email

The U.S. Food and Drug Administration says it is a constant balancing act to determine how much risk to consumers is acceptable in the drug approval process. No risk would result in few drugs coming to market. Some risk allows more. But Dr. Steve Galson, director of the FDA’s Center for Drug Evaluation and Research, tells PodTech’s Jason Lopez that the fate of drug companies — including startups that must get approval to stay in business — are not part of the Administration’s consideration. They spoke at Health Care Innovations 2006.

Tags: ,
Posted in: Connected Social Media, Dow Jones VentureWire, Healthcare, Tech Conferences and Events, Technology